It possibly stems from the shared immunologic features of hypogammaglobulinemia and normal B cell counts in the absence of remarkable facial abnormalities in our DNMT3B/ZBTB24-mutated patients. This evidence concerns the gene DNMT3B and agammaglobulinemia.